Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Finance Watch: Lots Of Money, Big And Small, Flowing Into Drug Development

Executive Summary

Big venture capital bets continue in biopharma, including Foresite's new $668m fund and Merck's $125m investment in Moderna, but small VC rounds could be making a comeback. In public company financings, Aslan and Evelo launched in the US, while Ascletis is testing Hong Kong’s IPO market.

Advertisement

Related Content

IPO Update: Returns Halved As Two Biopharmas Go Public In April; Unity Is May's First
Asia's Nasdaq? Hong Kong‘s Quest To Be IPO Power House Has Blessings And Curses
Finance Watch: Biopharma IPOs Defy Broader Stock Performance Trends
Finance Watch: Another Mega-Round As Moderna Bucks Biopharma's IPO Trend
Finance Watch: Raising Cash Before A Trump Slump, La Jolla Nabs $125m, Akcea Eyes $100m IPO
Ascletis Eyes Launch Of China’s First Oral HCV Drug, Possible IPO
VC Roundup: Cleave Raises $37m To Maintain Phase I Momentum, Plus $233.5m In Recent Financings
Merck, Amgen Invest In Medical Video Game Developer Akili
Record CStone Funding Heralds New Era For China Startups
Merck Bets Moderna's Cancer Vaccines Can Prime Patients For Immunotherapy

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC123068

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel